Company: BSX
Filing Date: 2025-02-18
Form Type: S-3ASR
Source: 0001104659-25-014808
Chunk: 24

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-02-18
Form: S-3ASR
Chunk 24
---
 (as defined in the indenture) in an aggregate principal amount not exceeding 20% of our Consolidated Tangible Assets (as defined in the indenture); and

(10)

Liens (not otherwise permitted pursuant to the indenture) (A) which secure obligations not exceeding (as to Boston Scientific and all its Subsidiaries) the greater of (1) $250.0 million or (2) 20% of Consolidated Tangible Assets (as defined in the indenture), in each case in aggregate amount at any time outstanding, or (B) with respect to which Boston Scientific effectively provides that the debt securities outstanding under the indenture are secured equally and ratably with (or, at Boston Scientific’s option, prior to) the debt secured by such Lien.

#### Defeasance
If so specified in the prospectus supplement with respect to debt securities of any series, the applicable issuer, at its option:

(1)

will be discharged from any and all obligations in respect of the debt securities of that series (except for certain obligations to register the transfer or exchange of debt securities of that series, replace stolen, lost or mutilated debt securities of that series, maintain paying agencies, and hold money for payment in trust); or

(2)

will not be subject to certain specified covenants with respect to the debt securities of that series as set forth in the related prospectus supplement,

in each case if there is deposited with the trustee, in trust, money or Government Obligations (as defined in the indenture) which through the payment of interest thereon and principal thereof in accordance with their terms will provide money in an amount sufficient to pay all the principal (including any mandatory sinking fund payments) of, and interest on, the outstanding debt securities of that series on the dates such payments are due in accordance with the terms of such debt securities. If the applicable issuer exercises the defeasance option with respect to debt securities of any series, the guarantees by each guarantor of such series of debt securities will be released concurrently with the defeasance of the debt securities of that series.

To exercise any such option, the applicable issuer or the applicable guarantor is required to deliver to the trustee an opinion of counsel to the effect that the deposit and related defeasance would not cause the beneficial owners of the debt securities of that series to recognize income, gain or loss for U.S. federal income tax purposes and, in the case of a discharge pursuant to (1) above,